https://www.taxtmi.com/news?id=50178 Guidance for Indian patients initiating Mounjaro (tirzepatide) provides a week by week framework for the first month covering injection initiation and site rotation, early transient symptoms from slowed gastric emptying, emerging glycaemic stability and reduced post meal spikes, appetite suppression and early weight changes, a timeline of common side effects (nausea, constipation, taste changes, mood shifts), rare serious risks (possible pancreatitis, allergic reactions), when to contact a clinician, missed dose instructions within a four day window, available dose strengths, and the need for ongoing clinical follow up and individualized dose adjustments. en-us Tue, 22 Jul 2025 17:46:14 +0530 Tue, 22 Jul 2025 17:46:14 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=50178 Guidance for Indian patients initiating Mounjaro (tirzepatide) provides a week by week framework for the first month covering injection initiation and site rotation, early transient symptoms from slowed gastric emptying, emerging glycaemic stability and reduced post meal spikes, appetite suppression and early weight changes, a timeline of common side effects (nausea, constipation, taste changes, mood shifts), rare serious risks (possible pancreatitis, allergic reactions), when to contact a clinician, missed dose instructions within a four day window, available dose strengths, and the need for ongoing clinical follow up and individualized dose adjustments. News - Tue, 22 Jul 2025 17:46:14 +0530 https://www.taxtmi.com/news?id=50178